Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Safety and Efficacy of Peri-procedure Blood Pressure Management of Revascularization for Ischemic Cerebral Vascular Disease

NCT03256513 is registered in ClinicalTrials.gov with Xuanwu Hospital, Beijing as lead sponsor.

NCT NCT03256513
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03256513 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Safety and Efficacy of Peri-procedure Blood Pressure Management of Revascularization for Ischemic Cerebral Vascular Disease
Lead sponsor
Xuanwu Hospital, Beijing
Phase
Not applicable
Overall status
Unknown status
Start date
April 10, 2017
Completion date
June 1, 2019
Enrollment
2,270 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cerebral revascularization, ischemic cerebrovascular disease